ContractCredit Agreement • July 7th, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 2 TO CREDIT AGREEMENT, dated as of July 2, 2014 (this “Amendment”), among PDL BIOPHARMA, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto and ROYAL BANK OF CANADA, as administrative agent (in such capacity, the “Administrative Agent”) for the Lenders (such capitalized term and, unless otherwise specified, all other capitalized terms not otherwise defined herein shall have the meanings set forth in the Credit Agreement referred to below).
